Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Antibiotics Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Antibiotics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cephalosporins
      • 1.3.3 Penicillins
      • 1.3.4 Fluoroquinolones
      • 1.3.5 Macrolides
      • 1.3.6 Carbapenems
      • 1.3.7 Aminoglycosides
      • 1.3.8 Sulfonamides
      • 1.3.9 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Antibiotics Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinics
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Antibiotics Market Size
      • 2.1.1 Global Antibiotics Revenue 2014-2025
      • 2.1.2 Global Antibiotics Sales 2014-2025
    • 2.2 Antibiotics Growth Rate by Regions
      • 2.2.1 Global Antibiotics Sales by Regions 2014-2019
      • 2.2.2 Global Antibiotics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Antibiotics Sales by Manufacturers
      • 3.1.1 Antibiotics Sales by Manufacturers 2014-2019
      • 3.1.2 Antibiotics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Antibiotics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antibiotics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Antibiotics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Antibiotics Price by Manufacturers
    • 3.4 Key Manufacturers Antibiotics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Antibiotics Market
    • 3.6 Key Manufacturers Antibiotics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Cephalosporins Sales and Revenue (2014-2019)
      • 4.1.2 Penicillins Sales and Revenue (2014-2019)
      • 4.1.3 Fluoroquinolones Sales and Revenue (2014-2019)
      • 4.1.4 Macrolides Sales and Revenue (2014-2019)
      • 4.1.5 Carbapenems Sales and Revenue (2014-2019)
      • 4.1.6 Aminoglycosides Sales and Revenue (2014-2019)
      • 4.1.7 Sulfonamides Sales and Revenue (2014-2019)
      • 4.1.8 Other Sales and Revenue (2014-2019)
    • 4.2 Global Antibiotics Sales Market Share by Type
    • 4.3 Global Antibiotics Revenue Market Share by Type
    • 4.4 Antibiotics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Antibiotics Sales by Application

    6 United States

    • 6.1 United States Antibiotics Breakdown Data by Company
    • 6.2 United States Antibiotics Breakdown Data by Type
    • 6.3 United States Antibiotics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Antibiotics Breakdown Data by Company
    • 7.2 European Union Antibiotics Breakdown Data by Type
    • 7.3 European Union Antibiotics Breakdown Data by Application

    8 China

    • 8.1 China Antibiotics Breakdown Data by Company
    • 8.2 China Antibiotics Breakdown Data by Type
    • 8.3 China Antibiotics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Antibiotics Breakdown Data by Company
    • 9.2 Rest of World Antibiotics Breakdown Data by Type
    • 9.3 Rest of World Antibiotics Breakdown Data by Application
    • 9.4 Rest of World Antibiotics Breakdown Data by Countries
      • 9.4.1 Rest of World Antibiotics Sales by Countries
      • 9.4.2 Rest of World Antibiotics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Antibiotics
      • 10.1.4 Antibiotics Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Janssen Pharmaceuticals
      • 10.2.1 Janssen Pharmaceuticals Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Antibiotics
      • 10.2.4 Antibiotics Product Introduction
      • 10.2.5 Janssen Pharmaceuticals Recent Development
    • 10.3 Abbott
      • 10.3.1 Abbott Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Antibiotics
      • 10.3.4 Antibiotics Product Introduction
      • 10.3.5 Abbott Recent Development
    • 10.4 GlaxoSmithKline
      • 10.4.1 GlaxoSmithKline Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Antibiotics
      • 10.4.4 Antibiotics Product Introduction
      • 10.4.5 GlaxoSmithKline Recent Development
    • 10.5 Sanofi
      • 10.5.1 Sanofi Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Antibiotics
      • 10.5.4 Antibiotics Product Introduction
      • 10.5.5 Sanofi Recent Development
    • 10.6 Novartis
      • 10.6.1 Novartis Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Antibiotics
      • 10.6.4 Antibiotics Product Introduction
      • 10.6.5 Novartis Recent Development
    • 10.7 Bayer
      • 10.7.1 Bayer Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Antibiotics
      • 10.7.4 Antibiotics Product Introduction
      • 10.7.5 Bayer Recent Development
    • 10.8 Bristol Myers Squibb Company
      • 10.8.1 Bristol Myers Squibb Company Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Antibiotics
      • 10.8.4 Antibiotics Product Introduction
      • 10.8.5 Bristol Myers Squibb Company Recent Development
    • 10.9 Eli Lilly and Company
      • 10.9.1 Eli Lilly and Company Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Antibiotics
      • 10.9.4 Antibiotics Product Introduction
      • 10.9.5 Eli Lilly and Company Recent Development
    • 10.10 Astellas Pharma
      • 10.10.1 Astellas Pharma Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Antibiotics
      • 10.10.4 Antibiotics Product Introduction
      • 10.10.5 Astellas Pharma Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Antibiotics Sales Channels
      • 11.2.2 Antibiotics Distributors
    • 11.3 Antibiotics Customers

    12 Market Forecast

    • 12.1 Global Antibiotics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Antibiotics Sales Forecast by Type
    • 12.3 Global Antibiotics Sales Forecast by Application
    • 12.4 Antibiotics Forecast by Regions
      • 12.4.1 Global Antibiotics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Antibiotics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
      More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.
      In 2019, the market size of Antibiotics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antibiotics.

      This report studies the global market size of Antibiotics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Antibiotics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Janssen Pharmaceuticals
      Abbott
      GlaxoSmithKline
      Sanofi
      Novartis
      Bayer
      Bristol Myers Squibb Company
      Eli Lilly and Company
      Astellas Pharma

      Market Segment by Product Type
      Cephalosporins
      Penicillins
      Fluoroquinolones
      Macrolides
      Carbapenems
      Aminoglycosides
      Sulfonamides
      Other

      Market Segment by Application
      Hospital
      Clinics
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Antibiotics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Antibiotics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Antibiotics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now